Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal folate receptor autoantibodies and cleft lip and/or palate.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2006
Same author

Renal impairment and diabetes mellitus after liver transplant.

Transplantation proceedings·2004
Same author

Persistent thrombocytopenia in liver transplant patients.

Transplantation proceedings·2004
Same author

Transcobalamin II expression is regulated by transcription factor(s) binding to a hexameric sequence (TGGTCC) in the promoter region of the gene.

Archives of biochemistry and biophysics·2002
Same author

Folate deficiency reduces the GPI-anchored folate-binding protein in rat renal tubules.

American journal of physiology. Cell physiology·2001
Same author

Radioenzymatic assay for reductive catalysis of N(5)N(10)-methylenetetrahydrofolate by methylenetetrahydrofolate reductase.

Journal of biochemical and biophysical methods·2000

Related Experiment Video

Updated: Jul 8, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

Further observations on the folate-binding factor in some leukemic cells.

S P Rothenberg, M DaCosta

    The Journal of Clinical Investigation
    |March 1, 1971
    PubMed
    Summary

    Researchers discovered a macromolecular factor in chronic myelogenous leukemia patients that binds folic acid. This novel folate binder

    Area of Science:

    • Biochemistry
    • Oncology
    • Molecular Biology

    Background:

    • Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm.
    • Folate metabolism plays a crucial role in DNA synthesis and cell proliferation.
    • Understanding molecular interactions in leukemia can reveal new therapeutic targets.

    Purpose of the Study:

    • To identify and characterize a macromolecular factor in CML patients that binds folic acid.
    • To investigate the properties and potential function of this folate-binding factor.
    • To explore the implications of this binding factor in CML pathogenesis and drug resistance.

    Main Methods:

    • Analysis of peripheral cell lysates and serum from CML patients.
    • Chromatographic separation using Sephadex G-75, G-100, and G-200 columns.

    More Related Videos

    Assessment of the Metabolic Profile of Primary Leukemia Cells
    06:21

    Assessment of the Metabolic Profile of Primary Leukemia Cells

    Published on: November 21, 2018

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
    06:35

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

    Published on: February 8, 2019

    Related Experiment Videos

    Last Updated: Jul 8, 2026

    Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
    14:04

    Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

    Published on: March 25, 2016

    Assessment of the Metabolic Profile of Primary Leukemia Cells
    06:21

    Assessment of the Metabolic Profile of Primary Leukemia Cells

    Published on: November 21, 2018

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
    06:35

    An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

    Published on: February 8, 2019

  • Binding assays with tritiated folic acid and various folate analogs.
  • Enzyme activity assays with folate reductase.
  • Stability studies at different pH and temperatures.
  • Competitive inhibition assays.

    • Main Results:

    • A macromolecular factor binding tritiated folic acid was identified in CML patient samples.
    • The factor exhibited rapid binding kinetics and slow dissociation, with stability at 56°C and acidic pH.
    • It was separable from endogenous folate reductase.
    • While unlabeled folic acid was a strong inhibitor, other folate derivatives showed weaker or no inhibition.
    • Dihydrofolate and methotrexate inhibited binding, suggesting a potential role in drug resistance.

    Conclusions:

    • A novel folate-binding macromolecular factor exists in CML.
    • This factor's interaction with dihydrofolate suggests a potential link to DNA synthesis pathways.
    • The binding of methotrexate may contribute to CML cell resistance to antifolate drugs.